amifampridine has been researched along with fomesafen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capková, K; Garcia, CC; Hognason, K; Jacobson, AR; Janda, KD; McArdle, JJ; Moe, ST; Potian, JG; Thyagarajan, B | 1 |
| Baskaran, P; Thyagarajan, B | 1 |
| Almodovar, JL; Bansagi, B; Hasan, BA; Herrmann, DN; Horvath, R; Littleton, JT; Lochmüller, H; Lofra, RM; Logigian, EL; Sowden, JE; Whittaker, RG; Zuchner, S | 1 |
3 other study(ies) available for amifampridine and fomesafen
| Article | Year |
|---|---|
Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.
Topics: 4-Aminopyridine; Acetylcholine; Amifampridine; Animals; Antidotes; Botulinum Toxins, Type A; Calcium; Cell Line, Tumor; Cinnamates; Hydroxamic Acids; In Vitro Techniques; Metalloexopeptidases; Mice; Muscle Contraction; Muscle, Skeletal; Neuromuscular Junction; Reflex | 2010 |
Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction.
Topics: 4-Aminopyridine; Acetylcholine; Acetylcholinesterase; Amifampridine; Animals; Botulinum Toxins, Type A; Calcium Ionophores; Cell Line, Tumor; Electric Stimulation; Electromyography; Evoked Potentials, Motor; In Vitro Techniques; Ionomycin; Mice; Mice, Inbred C57BL; Neuroblastoma; Neuromuscular Agents; Neuromuscular Junction; Potassium Channel Blockers; Reflex; Time Factors | 2014 |
Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.
Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Amifampridine; Child; Electrophysiological Phenomena; Female; Humans; Male; Middle Aged; Mutation; Myasthenic Syndromes, Congenital; Potassium Channel Blockers; Pyridostigmine Bromide; Reflex; Synaptic Transmission; Synaptotagmin II; Young Adult | 2015 |